- Fluidra‘s first-half net income rose by 21% year-over-year to €135.5 million, surpassing the estimate of €133 million.
- Sales increased by 4.8% compared to the previous year, reaching €1.23 billion, and beat the market estimate of €1.22 billion.
- The company reported an adjusted EBITDA of €314 million, marking a 6.1% increase from the previous year.
- Adjusted EBITA also saw a rise, reaching €264 million, which is a 5.6% improvement year-over-year.
- Market analysts have given Fluidra 10 buy ratings, 7 hold ratings, and 1 sell rating.
“`
A look at Fluidra Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Fluidra SA, a leading player in the pool and wellness industry, appears to be positioned for stable long-term growth based on its Smartkarma Smart Scores. With a balanced outlook across various factors, the company received a solid score of 3 in Value, Dividend, Growth, and Resilience, indicating a steady performance in these areas. Additionally, boasting a Momentum score of 4, Fluidra seems to be gaining traction and showing positive trends in the market. This combination of factors suggests that Fluidra may have a promising long-term outlook ahead.
Specializing in manufacturing and marketing equipment for residential and commercial swimming pools and wellness facilities, Fluidra‘s global presence provides it with a diverse market reach. Given its consistent scores across key aspects, investors may view Fluidra as a reliable investment option in the pool and wellness sector. Overall, the company’s balanced Smartkarma Smart Scores reflect a stable foundation for potential growth and resilience in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
